公开(公告)号：US20220361758A1

公开(公告)日：2022-11-17

申请号：US17763033

申请日：2020-09-24

申请人： JANSSEN PHARMACEUTICALS, INC.

发明人： Francesco N. ALBERTINI ,  Gregory J. BAKOS ,  Jeffrey DANIEL ,  Anthony R. DIUBALDI ,  James A. FLEMING ,  Jason L. HARRIS ,  Kevin L. HOUSER ,  Emma Louise HUBERT ,  Michael HUTCHINSON ,  David KALIKHMAN ,  Monica A. KAPIL ,  Wouter Jacques Noel LEQUIEU ,  David RAMOS ,  Ian SCRIMGEOUR ,  Frederick E. SHELTON, IV ,  Jaskaran SINGH ,  Steven M. VESOLE ,  Jingli WANG ,  Hong YAN

IPC分类号： A61B5/024 ,  A61B5/00

摘要： In general, drug administration devices configured to communicate with networks and external devices are provided. In an exemplary embodiment, a drug administration device is configured to adjust an operational parameter of the drug administration device based on a data packet formed from drug administration data ancillary data received from networks and/or external devices. In another example embodiment, a drug administration device is configured to scan for and establish communications with at least one external device. In another example embodiment, a method includes assessing whether to update a control program on a drug administration device from a network or external device. In another example embodiment, a system includes a first drug administration device configured to communicate with a second drug administration device to optimize a drug treatment.

公开(公告)号：US20240226464A1

公开(公告)日：2024-07-11

申请号：US17763585

申请日：2020-09-24

申请人： JANSSEN PHARMACEUTICALS, INC.

发明人： Francesco N. ALBERTINI ,  Gregory J. BAKOS ,  Michael A. BARATTA ,  Michael CANNAMELA ,  Anthony R. DIUBALDI ,  Yueheng DOU ,  Wayne DREVETS ,  James A. FLEMING ,  Jason L. HARRIS ,  Kevin L. HOUSER ,  Emma Louise HUBERT ,  Michael HUTCHINSON ,  Monica A. KAPIL ,  Peter KRULEVITCH ,  Chaley John LARSON ,  Wouter Jacques Noel LEQUIEU ,  Kui LIU, IV ,  Frederick E. SHELTON, IV ,  George SZABO ,  Steven M. VESOLE ,  Jingli WANG ,  Hong YAN

IPC分类号： A61M15/00 ,  G06T7/00

CPC分类号： A61M15/0003 ,  A61M15/0066 ,  G06T7/00 ,  A61M2205/52 ,  A61M2230/201 ,  A61M2230/30 ,  A61M2230/50

摘要： Provided herein are drug administration devices, methods, and systems for adjusting drug delivery to a patient to allow drug dosage to be adjusted based on a variety of different factors influencing the patient during administration of the drug. In one embodiment, a drug administration device or system can have a drug holder with a drug therein to be delivered to a patient, one or more sensors that are configured to gather various data associated with the patient, and at least one processor that can analyze the data gathered by the one or more sensors and adjust delivery of the drug based on the data.

公开(公告)号：US20230040329A1

公开(公告)日：2023-02-09

申请号：US17783815

申请日：2020-12-02

申请人： JANSSEN PHARMACEUTICALS, INC.

发明人： James A. FLEMING ,  Anthony R. DIUBALDI ,  Rudolph CEDRO, JR.

IPC分类号： A61M25/00 ,  A61M25/04 ,  A61M25/06

摘要： Various exemplary methods and devices (10, 110, 210) for delivering liquid therapeutic agents in solid tumors are provided. In general, a delivery device configured to deliver a liquid therapeutic agent into a solid tumor or other soft tissue can be configured to compress tissue and seal any fluid gaps around the delivery device during the delivery of the liquid therapeutic agent. In an exemplary embodiment the delivery device includes three elongate tubular shafts (12, 14, 16, 112, 114, 116, 212, 214, 216) configured to move longitudinally relative to one another. The elongate tubular shafts are configured to cooperate with one another to deliver the liquid therapeutic agent through a passageway of the delivery device to the solid tumor or other soft tissue and seal any fluid gaps around the delivery device while the liquid therapeutic agent is delivered into the solid tumor or other soft tissue.